elesclomol: Clinical Trials

1 trial of elesclomol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow elesclomol: new trials by email Literature Review of elesclomol trials Research Report on elesclomol

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
Elesclomol (STA-4783), Paclitaxel - Melanoma
Phase 3TerminatedSynta Pharmaceuticals Corp.6302007-08-012014-03-04

Conditions studied

Melanoma (1)  ·  Neoplasms (1)

Sponsors

Synta Pharmaceuticals Corp. (1)

Countries

Australia (1)  ·  Canada (1)  ·  Germany (1)  ·  Puerto Rico (1)  ·  Romania (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 23401447